Literature DB >> 22297326

The calcitonin levels can sometimes mislead parathyroid surgeons in patients with chronic kidney disease and renal hyperparathyroidism: report of a case.

Ralph Schneider1, Johanna E Schaumburg, Detlef K Bartsch, Katja Schlosser.   

Abstract

Renal hyperparathyroidism (rHPT) as a consequence of an abnormal calcium balance is a frequent complication in patients with chronic kidney disease (CKD). However, calcium homeostasis is also regulated by calcitonin. The relevance of elevated calcitonin levels in patients with rHPT is unclear. This report presents a case of a patient with CKD and mild rHPT scheduled for thyroidectomy for a suspected medullary thyroid carcinoma (MTC) within a mononodular goiter. A hemithyroidectomy with resection of both adjacent parathyroid glands and unilateral central lymph node dissection was performed. Histopathology revealed no evidence of MTC. The rHPT, calcitonin and pentagastrin test subsequently normalized and follow-up revealed no evidence for MTC within the remaining right thyroid lobe. Elevated calcitonin levels in patients with CKD may reflect a physiological response to rHPT than rather represent MTC. The thresholds for calcitonin levels need to be better defined in affected patients to determine the optimal extent of surgical resection.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 22297326     DOI: 10.1007/s00595-012-0131-y

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  31 in total

1.  Laboratory medicine practice guidelines. Laboratory support for the diagnosis and monitoring of thyroid disease.

Authors:  Zubair Baloch; Pierre Carayon; Bernard Conte-Devolx; Laurence M Demers; Ulla Feldt-Rasmussen; Jean-François Henry; Virginia A LiVosli; Patricia Niccoli-Sire; Rhys John; Jean Ruf; Peter P A Smyth; Carole A Spencer; Jan R Stockigt
Journal:  Thyroid       Date:  2003-01       Impact factor: 6.568

2.  Laboratory medicine practice guidelines: laboratory support for the diagnosis and monitoring of thyroid disease.

Authors:  L M Demers; C A Spencer
Journal:  Clin Endocrinol (Oxf)       Date:  2003-02       Impact factor: 3.478

Review 3.  The calcitonin conundrum--is it time for routine measurement of serum calcitonin in patients with thyroid nodules?

Authors:  Steven P Hodak; Kenneth D Burman
Journal:  J Clin Endocrinol Metab       Date:  2004-02       Impact factor: 5.958

4.  Renal metabolism of calcitonin.

Authors:  R E Simmons; J T Hjelle; C Mahoney; L J Deftos; W Lisker; P Kato; R Rabkin
Journal:  Am J Physiol       Date:  1988-04

5.  Calcitonin concentrations in patients with chronic kidney disease and medullary thyroid carcinoma or c-cell hyperplasia.

Authors:  K A Borchhardt; H Heinzl; A Gessl; W H Hörl; K Kaserer; G Sunder-Plassmann
Journal:  Kidney Int       Date:  2006-10-18       Impact factor: 10.612

6.  Can sporadic medullary thyroid carcinoma be biochemically predicted? Prospective analysis of 66 operated patients with elevated serum calcitonin levels.

Authors:  Maurizio Iacobone; Patricia Niccoli-Sire; Frederic Sebag; Catherine De Micco; Jean-François Henry
Journal:  World J Surg       Date:  2002-05-21       Impact factor: 3.352

7.  Normal preoperative calcitonin levels do not always exclude medullary thyroid carcinoma in patients with large palpable thyroid masses.

Authors:  A H Redding; S N Levine; M R Fowler
Journal:  Thyroid       Date:  2000-10       Impact factor: 6.568

8.  Calcitonin, an enigmatic hormone: does it have a function?

Authors:  P F Hirsch; G E Lester; R V Talmage
Journal:  J Musculoskelet Neuronal Interact       Date:  2001-06       Impact factor: 2.041

9.  Intractable pruritus as a manifestation of secondary hyperparathyroidism in uremia. Disappearance of itching after subtotal parathyroidectomy.

Authors:  S G Massry; M M Popovtzer; J W Coburn; D L Makoff; M H Maxwell; C R Kleeman
Journal:  N Engl J Med       Date:  1968-09-26       Impact factor: 91.245

10.  Determination of silica-purified plasma calcitonin for the detection and management of medullary thyroid carcinoma: comparison of two provocative tests.

Authors:  H Gharib; P C Kao; H Heath
Journal:  Mayo Clin Proc       Date:  1987-05       Impact factor: 7.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.